Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Kornstein, S. G. Articles by Keller, M. B. Search for Related Content PubMed Citation Articles by Kornstein, S. G. Articles by Keller, M. B. Gender Depression Antidepressants

Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression

OBJECTIVE: The authors examined gender differences in treatment response to sertraline, a selective serotonin reuptake inhibitor (SSRI), and to imipramine, a tricyclic antidepressant, in chronic depression. METHOD: A total of 235 male and 400 female outpatients with DSM-III-R chronic major depression or double depression (i.e., major depression superimposed on dysthymia) were randomly assigned to 12 weeks of double-blind treatment with sertraline or with imipramine after placebo washout. RESULTS: Women were significantly more likely to show a favorable response to sertraline than to imipramine, and men were significantly more likely to show a favorable response to imipramine than to sertraline. Gender and type of medication were also significantly related to dropout rates; women who were taking imipramine and men who were taking sertraline were more likely to withdraw from the study. Gender differences in time to response were seen with imipramine, with women responding significantly more slowly than men. Comparison of treatment response rates by menopausal status showed that premenopausal women responded significantly better to sertraline than to imipramine and that postmenopausal women had similar rates of response to the two medications. CONCLUSIONS: Men and women with chronic depression show differential responsivity to and tolerability of SSRIs and tricyclic antidepressants. The differing response rates between the drug classes in women was observed primarily in premenopausal women. Thus, female sex hormones may enhance response to SSRIs or inhibit response to tricyclics. Both gender and menopausal status should be considered when choosing an appropriate antidepressant for a depressed patient.

This article has been cited by other articles:

				V. K. Burt, M. M. Wohlreich, C. H. Mallinckrodt, M. J. Detke, J. G. Watkin, and D. E. Stewart Duloxetine for the Treatment of Major Depressive Disorder in Women Ages 40 to 55 Years Psychosomatics, August 1, 2005; 46(4): 345 - 354. [Abstract] [Full Text] [PDF]

				P. J. SCHMIDT Depression, the Perimenopause, and Estrogen Therapy Ann. N.Y. Acad. Sci., June 1, 2005; 1052(1): 27 - 40. [Abstract] [Full Text] [PDF]

				N. Carretti, P. Florio, A. Bertolin, C.V.L. Costa, G. Allegri, and G. Zilli Serum fluctuations of total and free tryptophan levels during the menstrual cycle are related to gonadotrophins and reflect brain serotonin utilization Hum. Reprod., June 1, 2005; 20(6): 1548 - 1553. [Abstract] [Full Text] [PDF]

				Z. Amin, T. Canli, and C. N. Epperson Effect of Estrogen-Serotonin Interactions on Mood and Cognition Behav Cogn Neurosci Rev, March 1, 2005; 4(1): 43 - 58. [Abstract] [PDF]

				D.P. Devanand, M. S. Nobler, J. Cheng, N. Turret, G. H. Pelton, S. P. Roose, and H. A. Sackeim Randomized, Double-Blind, Placebo-Controlled Trial of Fluoxetine Treatment for Elderly Patients With Dysthymic Disorder Am J Geriatr Psychiatry, January 1, 2005; 13(1): 59 - 68. [Abstract] [Full Text] [PDF]

				L. J. Fochtmann and A. J. Gelenberg Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition Focus, January 1, 2005; 3(1): 34 - 42. [Full Text] [PDF]

				C. B. Nemeroff, C. M. Heim, M. E. Thase, D. N. Klein, A. J. Rush, A. F. Schatzberg, P. T. Ninan, J. P. McCullough Jr., P. M. Weiss, D. L. Dunner, et al. Differential Responses to Psychotherapy Versus Pharmacotherapy in Patients With Chronic Forms of Major Depression and Childhood Trauma Focus, January 1, 2005; 3(1): 131 - 135. [Abstract] [Full Text] [PDF]

				W. S. Tse and A. J. Bond Sex differences in cortisol response to reboxetine J Psychopharmacol, January 1, 2005; 19(1): 46 - 50. [Abstract] [PDF]

				A. Khan, R. L. Kolts, M. E. Thase, K. R. R. Krishnan, and W. Brown Research Design Features and Patient Characteristics Associated With the Outcome of Antidepressant Clinical Trials Am J Psychiatry, November 1, 2004; 161(11): 2045 - 2049. [Abstract] [Full Text] [PDF]

				T. Wohlfarth, J. G. Storosum, A. J.A. Elferink, B. J. van Zwieten, A. Fouwels, and W. van den Brink Response to Tricyclic Antidepressants: Independent of Gender? Am J Psychiatry, February 1, 2004; 161(2): 370 - 372. [Abstract] [Full Text] [PDF]

				C. B. Nemeroff, C. M. Heim, M. E. Thase, D. N. Klein, A. J. Rush, A. F. Schatzberg, P. T. Ninan, J. P. McCullough Jr., P. M. Weiss, D. L. Dunner, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma PNAS, November 25, 2003; 100(24): 14293 - 14296. [Abstract] [Full Text] [PDF]

				M. G. Hildebrandt, E. W. Steyerberg, K. B. Stage, J. Passchier, P. Kragh-Soerensen, and The Danish University Antidepressant Group Are Gender Differences Important for the Clinical Effects of Antidepressants? Am J Psychiatry, September 1, 2003; 160(9): 1643 - 1650. [Abstract] [Full Text] [PDF]

				S. Y. El-Ibiary and K. C. Lee Novel Uses of Selective Serotonin Reuptake Inhibitors in Women Journal of Pharmacy Practice, June 1, 2003; 16(3): 191 - 199. [Abstract] [PDF]

				A. H. Clayton and J. Kaltsounis-Puckett Combination Therapy in the Treatment of Major Depressive Disorder Complicated by Fibromyalgia and Menopause Psychosomatics, December 1, 2002; 43(6): 491 - 493. [Full Text] [PDF]

				F. M. Quitkin, J. W. Stewart, P. J. McGrath, B. P. Taylor, M. S. Tisminetzky, E. Petkova, Y. Chen, G. Ma, and D. F. Klein Are There Differences Between Women's and Men's Antidepressant Responses? Am J Psychiatry, November 1, 2002; 159(11): 1848 - 1854. [Abstract] [Full Text] [PDF]

				A. Neumeister, A. Konstantinidis, J. Stastny, M. J. Schwarz, O. Vitouch, M. Willeit, N. Praschak-Rieder, J. Zach, M. de Zwaan, B. Bondy, et al. Association Between Serotonin Transporter Gene Promoter Polymorphism (5HTTLPR) and Behavioral Responses to Tryptophan Depletion in Healthy Women With and Without Family History of Depression Arch Gen Psychiatry, July 1, 2002; 59(7): 613 - 620. [Abstract] [Full Text] [PDF]

				L. J. Miller Postpartum Depression JAMA, February 13, 2002; 287(6): 762 - 765. [Full Text] [PDF]

				A. H. Young Gender differences in treatment response to antidepressants The British Journal of Psychiatry, December 1, 2001; 179(6): 561 - 561. [Full Text]

				A. H Young Men and women with chronic major depression responded differently to sertraline and imipramine Evid. Based Ment. Health, November 1, 2001; 4(4): 114 - 114. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us